Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("TAKENAGA, K")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 67

  • Page / 3
Export

Selection :

  • and

STIMULATION BY RETINOIC ACID OF PROSTAGLANDIN PRODUCTION AND ITS INHIBITION BY TUMOR PROMOTERS IN MOUSE MYELOID LEUKEMIA CELLSTAKENAGA K.1981; GANN; ISSN 0016-450X; JPN; DA. 1981; VOL. 72; NO 4; PP. 488-497; BIBL. 27 REF.Article

DIFFERENCES IN INDUCIBILITY OF MORPHOLOGICAL DIFFERENTIATION OF PARENTAL CELLS, SELECTED VARIANT CELLS AND CELLS FROM SPONTANEOUS METASTASES OF MOUSE NEUROBLASTOMA CELLS = DIFFERENCES DANS L'INDUCTIBILITE DE LA DIFFERENCIATION MORPHOLOGIQUE DE CELLULES PARENTALES, DE VARIANTS CELLULAIRES SELECTIONNES ET DE CELLULES DE METASTASES SPONTANEES DE CELLULES DE NEUROBLASTOME PROVENANT DE SOURISTAKENAGA K.1983; CANCER LETTERS; ISSN 0304-3835; NLD; DA. 1983; VOL. 19; NO 1; PP. 41-46; ABS. ENG; BIBL. 14 REF.; GRAPHArticle

Effects of 8-bromoadenosine 3':5'-cyclic monophosphate on proteolytic enzymes, adhesiveness and lung-colonizing ability of cloned low-metastatic Lewis lung carcinoma cellsTAKENAGA, K.Japanese journal of cancer research. 1986, Vol 77, Num 10, pp 998-1004, issn 0910-5050Article

Characterization of low- and high-metastatic clones isolated from a Lewis lung carcinoma = Caractérisation de clones faiblement ou fortement métastatiques isolés de la tumeur du poumon de LewisTAKENAGA, K.Gann. 1984, Vol 75, Num 1, pp 61-71, issn 0016-450XArticle

Enhancement of lung-colonizing ability of cloned low-metastatic Lewis lung carcinoma cells by treatment with highly polar compoundsTAKENAGA, K.International journal of cancer. 1984, Vol 34, Num 1, pp 83-89, issn 0020-7136Article

Modification of the metastatic potential of tumor cells by drugsTAKENAGA, K.Cancer metastasis reviews. 1986, Vol 5, Num 2, pp 67-75, issn 0167-7659Article

Effect of butyric acid on lung-colonizing ability of cloned low-metastatic Lewis lung carcinoma cellsTAKENAGA, K.Cancer research (Baltimore). 1986, Vol 46, Num 3, pp 1244-1249, issn 0008-5472Article

Enhanced metastatic potential of cloned low-metastatic Lewis lung carcinoma cells treated in vitro with dimethyl sulfoxide = Augmentation du potentiel métastatique de cellules clonées du carcinome pulmonaire de Lewis faiblement métastatiques après traitement in vitro avec le diméthyl sulfoxydeTAKENAGA, K.Cancer research (Baltimore). 1984, Vol 44, Num 3, pp 1122-1127, issn 0008-5472Article

Suppression of metastasis-associated S100A4 gene expression by gamma-interferon in human colon adenocarcinoma cellsTAKENAGA, K.British journal of cancer. 1999, Vol 80, Num 1-2, pp 127-132, issn 0007-0920Article

INDUCTION BY CHLOROQUINE OF DIFFERENTIATION OF CULTERED MOUSE MYELOID LEUKEMIA CELLSTAKENAGA K; HOZUMI M.1980; GANN; JPN; DA. 1980; VOL. 71; NO 1; PP. 141-145; BIBL. 12 REF.Article

EFFECTS OF RETINOIDS ON INDUCTION OF DIFFERENTIATION OF CULTURED MOUSE MYELOID LEUKEMIA CELLSTAKENAGA K; HOZUMI M; SAKAGAMI Y et al.1980; CANCER RES.; USA; DA. 1980; VOL. 40; NO 3; PP. 914-919; BIBL. 38 REF.Article

INHIBITION OF DIFFERENTIATION OF MOUSE MYELOID LEUKEMIA CELLS BY PHENOLIC ANTIOXIDANTS AND ALPHA -TOCOPHEROLTAKENAGA K; HONMA Y; HOZUMI M et al.1981; GANN; ISSN 0016-450X; JPN; DA. 1981; VOL. 72; NO 1; PP. 104-112; BIBL. 41 REF.Article

MECHANISMS OF INHIBITION OF MOUSE MYELOID LEUKEMIC CELL DIFFERENTIATION BY PROSTAGLANDIN F2ALPHATAKENAGA K; HONMA Y; KADO J et al.1982; GANN; ISSN 0016-450X; JPN; DA. 1982; VOL. 73; NO 2; PP. 175-183; BIBL. 39 REF.Article

ROLE OF LEUKOCYTE IN ASCITES IN THE PRODUCTION OF FACTOR (S) STIMULATING DIFFERENTIATION OF MOUSE MYELOID LEUKEMIA CELLS.HOZUMI M; TAKENAGA K; TOMIDA M et al.1977; GANN; JAP.; DA. 1977; VOL. 68; NO 5; PP. 643-652; BIBL. 15 REF.Article

PRODUCTION OF DIFFERENTIATION-INHIBITING FACTOR IN CULTURED MOUSE MYELOID LEUKEMIA CELLS TREATED WITH RETINOIC ACIDTAKENAGA K; HONMA Y; OKABE KADO J et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 5; PP. 1948-1953; BIBL. 26 REF.Article

INDUCTION OF DIFFERENTIATION OF CULTURED HUMAN PROMYELOCYTIC LEUKEMIA CELLS BY RETINOIDSHONMA Y; TAKENAGA K; KASUKABE T et al.1980; BIOCHEM. BIOPHYS. RES. COMMUNIC.; USA; DA. 1980; VOL. 95; NO 2; PP. 507-512; BIBL. 12 REF.Article

A STATISTICAL PREDICTION FOR TYPHOON MOVEMENT USING NUMERICALLY FORECASTED DATA AS PREDICTORS.NOMOTO S; TAKENAGA K; SHIMAMURA M et al.1976; J. METEOROL. SOC. JAP.; JAP.; DA. 1976; VOL. 54; NO 2; PP. 99-104; ABS. JAP.; BIBL. 11 REF.Article

ENHANCEMENT BY DOUBLE-STRANDED POLYRIBONUCLEOTIDES OF PRODUCTION BY CULTURED MOUSE PERITONEAL MACROPHAGES OF DIFFERENTIATION-STIMULATING FACTOR (S) FOR MOUSE MYELOID LEUKAEMIC CELLSTOMIDA M; TAKENAGA K; YAMAMOTO Y et al.1978; BIOCHEM. J.; GBR; DA. 1978; VOL. 176; NO 3; PP. 665-669; BIBL. 11 REF.Article

Restoration of microfilament bundle organization in v-raf-transformed NRK cells after transduction with tropomyosin 2 cDNATAKENAGA, K; MASUDA, A.Cancer letters. 1994, Vol 87, Num 1, pp 47-53, issn 0304-3835Article

Effects of 12-O-tetradecanoylphorbol-13-acetate on adhesiveness and lung-colonizing ability of lewis lung carcinoma cellsTAKENAGA, K; TAKAHASHI, K.Cancer research (Baltimore). 1986, Vol 46, Num 1, pp 375-380, issn 0008-5472Article

Amplification method for crosstalk reduction in multi-core fibre amplifierONO, H; YAMADA, M; TAKENAGA, K et al.Electronics letters. 2013, Vol 49, Num 2, pp 138-140, issn 0013-5194, 3 p.Article

Antitumor effect of human pancreatic cancer cells transduced with cytokine genes which activate Th1 helper T cellsYOSHIDA, Y; TASAKI, K; KIMURAI, M et al.Anticancer research. 1998, Vol 18, Num 1A, pp 333-335, issn 0250-7005Article

Reduced tumorigenicity of human gastric carcinoma cells engineered to produce IL-2 in SCID mice reconstituted with peripheral blood cells from cancer patientsTAGAWA, M; GOTO, S; TAKENAGA, K et al.Cancer letters. 1998, Vol 123, Num 1, pp 87-93, issn 0304-3835Article

Loss of tumorigenicity of human pancreatic carcinoma cells engineered to produce interleukin-2 or interleukin-4 in nude mice : a potentiality for cancer gene therapyKIMURA, M; TAGAWA, M; TAKENAGA, K et al.Cancer letters. 1998, Vol 128, Num 1, pp 47-53, issn 0304-3835Article

Murine colon carcinoma cells engineered to produce human interleukin-2 induce tumor-specific anti-tumor responseGUNJI, Y; TAGAWA, M; OCHIAI, T et al.International journal of cancer. 1996, Vol 66, Num 1, pp 135-139, issn 0020-7136Article

  • Page / 3